<DOC>
	<DOC>NCT02279186</DOC>
	<brief_summary>In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss during and after elective LSCS will be investigated.</brief_summary>
	<brief_title>Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section</brief_title>
	<detailed_description>To state the effectiveness clinically and laboratory and safety of tranexamic acid in reducing blood loss during and after the elective lower segment cesarean section.</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Women undergoing caesarean delivery for various elective indications. Full term primiparas / multiparas. Singleton pregnancy being delivered by LSCS. Medical problems involving the heart, liver, kidney and brain . Blood disorders. Allergy to tranexamic acid. History of thromboembolic disorders, abnormal placentation, severe preeclampsia, uterine anomalies and pathology. Multiple pregnancy, macrosomia. Polyhydromnios . Patients requiring blood transfusion due to anemia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>